pharmacie et médicaments – Accès aux innovations thérapeutiques des patients atteints de myélome multiple

This written question concerns the access of patients with multiple myeloma to new and innovative therapeutic treatments. It highlights the importance of ensuring timely access to cutting-edge medicines for those affected by this serious condition. The question seeks to understand the current situation and potential barriers to accessing these advanced therapies, aiming to improve patient outcomes and quality of life.